Foscarnet
(DFHAXXVZCFXGOQ-UHFFFAOYSA-K)
Structure
- SMILES
- [O-]C(=O)P(=O)([O-])[O-].[Na+].[Na+].[Na+]
- Molecular Formula:
- CNa3O5P
- Molecular Weight:
- 191.951
- Log P:
- -0.6162
- Hydrogen Bond Acceptor:
- 5
- Hydrogen Bond Donor:
- 0
- TPSA:
- 113.13
- CAS Number(s):
- 63585-09-1
Synonym(s)
1.
Foscarnet
2.
Phosphonoformate
3.
Phosphonoformic Acid
4.
Foscarnet Barium (2:3) Salt
5.
Foscarnet Calcium (2:3) Salt
6.
Foscarnet Disodium Salt
7.
Foscarnet Magnesium (2:3) Salt
8.
Foscarnet Manganese (2+) (2:3) Salt
9.
Foscarnet Sodium
10.
Foscarnet Sodium Hexahydrate
11.
Foscarnet Trilithium Salt
12.
Foscarnet Tripotassium Salt
13.
Foscarnet Trisodium Salt
14.
Foscavir
15.
Trisodium Phosphonoformate
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Drug ineffective | FAERS: 17 | US FAERS | |
| 2 | Sepsis | FAERS: 7 | US FAERS | |
| 3 | Blood creatinine increased | FAERS: 6 | US FAERS | |
| 4 | Pneumonia | FAERS: 6 | US FAERS | |
| 5 | Renal tubular disorder | FAERS: 6 | US FAERS | |
| 6 | Accidental overdose | FAERS: 4 | US FAERS | |
| 7 | Acute kidney injury | FAERS: 4 | US FAERS | |
| 8 | Delirium | FAERS: 4 | US FAERS | |
| 9 | Nausea | FAERS: 3 | US FAERS | |
| 10 | Renal tubular acidosis | FAERS: 3 | US FAERS | |
| 11 | Shock | FAERS: 3 | US FAERS | |
| 12 | Vomiting | FAERS: 3 | US FAERS | |
| 13 | Blood potassium decreased | FAERS: 2 | US FAERS | |
| 14 | Chills | FAERS: 2 | US FAERS | |
| 15 | Cytomegalovirus chorioretinitis | FAERS: 2 | US FAERS | |
| 16 | Disease Progression | FAERS: 2 | US FAERS | |
| 17 | Drug ineffective for unapproved indication | FAERS: 2 | US FAERS | |
| 18 | Drug resistance | FAERS: 2 | US FAERS | |
| 19 | Dysuria | FAERS: 2 | US FAERS | |
| 20 | Electrolyte imbalance | FAERS: 2 | US FAERS | |
| 21 | Headache | FAERS: 2 | US FAERS | |
| 22 | Hypercreatininaemia | FAERS: 2 | US FAERS | |
| 23 | Medication Error | FAERS: 2 | US FAERS | |
| 24 | Neutropenia | FAERS: 2 | US FAERS | |
| 25 | Pancreatitis | FAERS: 2 | US FAERS | |
| 26 | Polyneuropathy | FAERS: 2 | US FAERS | |
| 27 | Product storage error | FAERS: 2 | US FAERS | |
| 28 | Respiratory Failure | FAERS: 2 | US FAERS | |
| 29 | Retinal Detachment | FAERS: 2 | US FAERS | |
| 30 | Urethritis | FAERS: 2 | US FAERS | |
| 31 | Abdominal Pain | FAERS: 1 | US FAERS | |
| 32 | Alanine Aminotransferase Increased | FAERS: 1 | US FAERS | |
| 33 | Alopecia | FAERS: 1 | US FAERS | |
| 34 | Altered state of consciousness | FAERS: 1 | US FAERS | |
| 35 | Anuria | FAERS: 1 | US FAERS | |
| 36 | Appendicitis | FAERS: 1 | US FAERS | |
| 37 | Application site reaction | FAERS: 1 | US FAERS | |
| 38 | Aspartate Aminotransferase Increased | FAERS: 1 | US FAERS | |
| 39 | Blood alkaline phosphatase increased | FAERS: 1 | US FAERS | |
| 40 | Blood lactate dehydrogenase increased | FAERS: 1 | US FAERS | |
| 41 | Bradycardia | FAERS: 1 | US FAERS | |
| 42 | Cardiac Arrest | FAERS: 1 | US FAERS | |
| 43 | Cerebral Infarction | FAERS: 1 | US FAERS | |
| 44 | Chest discomfort | FAERS: 1 | US FAERS | |
| 45 | Cholestasis | FAERS: 1 | US FAERS | |
| 46 | Colitis | FAERS: 1 | US FAERS | |
| 47 | Cystitis | FAERS: 1 | US FAERS | |
| 48 | Depressed Level of Consciousness | FAERS: 1 | US FAERS | |
| 49 | Diabetes Insipidus | FAERS: 1 | US FAERS | |
| 50 | Disease recurrence | FAERS: 1 | US FAERS | |
| 51 | Endocarditis | FAERS: 1 | US FAERS | |
| 52 | Failure to Thrive | FAERS: 1 | US FAERS | |
| 53 | Fanconi Syndrome | FAERS: 1 | US FAERS | |
| 54 | Fluid overload | FAERS: 1 | US FAERS | |
| 55 | Fungal test positive | FAERS: 1 | US FAERS | |
| 56 | Gamma-Glutamyltransferase Increased | FAERS: 1 | US FAERS | |
| 57 | Histiocytosis haematophagic | FAERS: 1 | US FAERS | |
| 58 | Hypotension | FAERS: 1 | US FAERS | |
| 59 | Hypoxia | FAERS: 1 | US FAERS | |
| 60 | Intestinal Obstruction | FAERS: 1 | US FAERS | |
| 61 | Inulin renal clearance decreased | FAERS: 1 | US FAERS | |
| 62 | Leukoencephalopathy | FAERS: 1 | US FAERS | |
| 63 | Memory impairment | FAERS: 1 | US FAERS | |
| 64 | Myelitis | FAERS: 1 | US FAERS | |
| 65 | Myocardial Infarction | FAERS: 1 | US FAERS | |
| 66 | Myocarditis | FAERS: 1 | US FAERS | |
| 67 | Nephrocalcinosis | FAERS: 1 | US FAERS | |
| 68 | Nephrolithiasis | FAERS: 1 | US FAERS | |
| 69 | Nephrotic Syndrome | FAERS: 1 | US FAERS | |
| 70 | Overdose | FAERS: 1 | US FAERS | |
| 71 | Pain | FAERS: 1 | US FAERS | |
| 72 | Pharyngolaryngeal Pain | FAERS: 1 | US FAERS | |
| 73 | Polydipsia | FAERS: 1 | US FAERS | |
| 74 | Polyuria | FAERS: 1 | US FAERS | |
| 75 | Posterior reversible encephalopathy syndrome | FAERS: 1 | US FAERS | |
| 76 | Product measured potency issue | FAERS: 1 | US FAERS | |
| 77 | Product substitution issue | FAERS: 1 | US FAERS | |
| 78 | Proteinuria | FAERS: 1 | US FAERS | |
| 79 | Rash erythematous | FAERS: 1 | US FAERS | |
| 80 | Renal mass | FAERS: 1 | US FAERS | |
| 81 | Renal pain | FAERS: 1 | US FAERS | |
| 82 | Renal tubular injury | FAERS: 1 | US FAERS | |
| 83 | Respiratory distress | FAERS: 1 | US FAERS | |
| 84 | Septic Shock | FAERS: 1 | US FAERS | |
| 85 | Skin irritation | FAERS: 1 | US FAERS | |
| 86 | Subclavian artery thrombosis | FAERS: 1 | US FAERS | |
| 87 | Tachycardia | FAERS: 1 | US FAERS | |
| 88 | Tetany | FAERS: 1 | US FAERS | |
| 89 | Toxicity to various agents | FAERS: 1 | US FAERS | |
| 90 | Urinary Retention | FAERS: 1 | US FAERS | |
| 91 | Viral myocarditis | FAERS: 1 | US FAERS | |
| 92 | nervous system disorder | FAERS: 1 | US FAERS | |
| 93 | treatment failure | FAERS: 1 | US FAERS | |
| 94 | Blood urea increased | Canada Vigilance: 1 | Canada Vigilance | |
| 95 | Meningitis | Canada Vigilance: 1 | Canada Vigilance | |
| 96 | Oliguria | Canada Vigilance: 1 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.